In Santo Domingo, marking World Prostate Cancer Day, the Dominican Society of Medical Oncology (SDOM) has launched a urgent public appeal, calling on Dominican men to prioritize routine preventive screening and break down deep-rooted cultural stigmas that currently hinder early diagnosis of the nation’s most prevalent male cancer.
SDOM President Ángela Cabreja underlined the life-saving importance of catching the disease in its earliest stages. Official data from the organization shows that when prostate cancer remains localized to the prostate gland, the five-year survival and cure rate tops 99%. Despite this promising statistic, Cabreja noted that a large share of patients only pursue medical care after the cancer has progressed to an advanced, harder-to-treat stage, a trend directly tied to cultural stigma around men’s health and preventive testing.
New figures from the Global Cancer Observatory paint a stark public health picture for the Dominican Republic: the country logs roughly 4,918 new prostate cancer diagnoses annually, and sees around 2,120 deaths linked to the disease each year. This places the Dominican Republic among the nations with the highest prostate cancer incidence rates across the Latin American and Caribbean region. Medical specialists have outlined key modifiable and non-modifiable risk factors for the disease, including advancing age, a family history of prostate cancer, inherited genetic mutations such as BRCA1 and BRCA2, excess body weight, sedentary lifestyles, and diets heavy in processed and saturated fats.
To guide public action, SDOM has outlined clear screening guidelines: all men aged 50 and older, as well as men 45 and older with a family history of the disease, should schedule annual urological check-ups. Oncological specialists recommend combining two complementary screening tools: the prostate-specific antigen (PSA) blood test and a digital rectal exam, emphasizing that neither test can adequately replace the other for comprehensive early detection.
SDOM also acknowledged that recent medical advances in prostate cancer treatment have dramatically improved patient outcomes and reduced the severity of treatment side effects in recent years. Even with these treatment gains, however, the organization reiterated that preventive care and early diagnosis remain the single most effective tools to reduce mortality from the disease. The society reaffirmed its ongoing commitment to expanding public awareness, increasing access to timely screening, and guaranteeing all Dominican prostate cancer patients access to high-quality, evidence-based care.